Phosphorothioate antisense oligonucleotides against basic fibroblast growth factor inhibit anchorage-dependent and anchorage-independent growth of a malignant glioblastoma cell line
Related Experiment Videos
1Department of Physiology and Biophysics, Dalhousie University, Halifax, Nova Scotia, Canada.
Abstract:
Basic fibroblast growth factor (bFGF) is a broad spectrum mitogen for many cells of neuroectodermal origin, including glial cells. The human malignant glioblastoma cell line U87-MG expresses high steady state levels of the bFGF mRNA and contains abundant stores of biologically active bFGF protein. In the present study we have examined the contribution of endogenous bFGF to the autocrine growth of these cells. Using reverse transcription-polymerase chain reaction, U87-MG cells were shown to express the mRNAs for both bFGF and the bFGF receptor, confirming the existence of the basic requirements for an autocrine loop. Addition of 5 microM bFGF-specific antisense oligonucleotide to U87-MG cultures significantly inhibited the growth rate of these cells within 48 h and blocked proliferation beyond 2 days. The corresponding bFGF-specific sense oligonucleotide did not significantly inhibit cell proliferation over the course of these experiments. Similarly, antisense oligonucleotides significantly inhibited colony formation in soft agar, while the sense sequence was without effect. Western blotting with antihuman bFGF revealed that U87-MG cells synthesize three isoforms of bFGF, approximately 18, 23, and 25 kilodaltons (kDa) in size. The 23- and 25-kDa isoforms together comprise approximately 80% of the total cellular stores of bFGF. Antisense treatment for 4 days reduced the abundance of the 23- and 25-kDa isoforms by 64-74%, but had little effect on the 18-kDa isoform. The inhibitory effect of the antisense oligonucleotides on anchorage-dependent proliferation was reversed by the addition of recombinant 18-kDa human bFGF.(ABSTRACT TRUNCATED AT 250 WORDS)
Insights
Endogenous basic fibroblast growth factor (bFGF) drives glioblastoma cell growth through an autocrine loop. Inhibiting bFGF with antisense oligonucleotides significantly reduced U87-MG cell proliferation and colony formation.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Basic fibroblast growth factor (bFGF) is a mitogen for neuroectodermal cells, including glial cells.
- Glioblastoma cell line U87-MG expresses high levels of bFGF mRNA and protein.
- Autocrine growth loops are implicated in cancer progression.
Purpose of the Study:
- To investigate the role of endogenous bFGF in the autocrine growth of U87-MG glioblastoma cells.
- To determine the effect of bFGF inhibition on glioblastoma cell proliferation and colony formation.
Main Methods:
- Reverse transcription-polymerase chain reaction (RT-PCR) to detect bFGF and bFGF receptor mRNA.
- Treatment with bFGF-specific antisense and sense oligonucleotides.
- Western blotting to analyze bFGF isoforms.
- Soft agar assays for colony formation.
- Recombinant bFGF addition to assess reversal of inhibition.
Main Results:
- U87-MG cells express mRNA for both bFGF and its receptor, indicating potential for autocrine signaling.
- bFGF-specific antisense oligonucleotides significantly inhibited U87-MG cell growth and proliferation.
- Antisense treatment reduced the abundance of 23- and 25-kDa bFGF isoforms.
- The inhibitory effect was reversed by adding recombinant 18-kDa bFGF.
Conclusions:
- Endogenous bFGF plays a crucial role in the autocrine growth of U87-MG glioblastoma cells.
- Targeting bFGF with antisense oligonucleotides offers a potential therapeutic strategy for glioblastoma.
- Different bFGF isoforms may have distinct roles in glioblastoma growth.